Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy.

Drug Des Devel Ther · 2016 · PMC5167476 · PMID 28008228

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This difference did not reach statistical significance (relative risk [RR] =1.40, 95% confidence interval [CI] =0.91–2.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.